Kenichi Saitoh

USPTO Granted Patents = 11 (Patent Applications = 2)

CIPO Patents = 5

EPO Patents = 5 (Patent Applications = 8)

Average Co-Inventor Count = 5.0

ph-index = 4

Forward Citations = 37(Granted Patents)

Location History:

Ohizumi-machi, JP (2003)
Nerima-ku, JP (2010)
Tokyo, JP (1995 - 2015)

Company Filing History:

9 out of 41

Zenyaku Kogyo Kabushiki Kaisha

patents

1 out of 12

Kabushiki Kaisha Nichibei

Years Active: 1995-2015

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9132130 - Purine derivative and antitumor agent using same (2015-09-15),

2. 9089561 - Methods for treating depression, neurodegeneration, inhibiting amyloid β deposition, delaying senescence, and extending life spans with heterocyclic compounds (2015-07-28),

3. 8563715 - Pyrimidine derivative having cell protecting effect and uses thereof (2013-10-22),

4. 7855199 - Heterocyclic compound and anti-malignant-tumor agent containing the same as active ingredient (2010-12-21),

5. 7803947 - Method for producing thiocarbamate derivative (2010-09-28),

6. 7767824 - Heterocyclic compounds and cerebral function improvers containing the same as the active ingredient (2010-08-03),

7. 7503845 - Game apparatus using body image appeared synchronized with inserted body (2009-03-17),

8. 7153853 - Heterocyclic compounds and antitumor drugs containing the same as the active ingredient (2006-12-26),

9. 7141579 - Heterocyclic compounds and cerebral function improvers containing the same as the active ingredient (2006-11-28),

10. 6635652 - Azaindolizinone derivatives and cerebral function improvers containing the same as the active ingredient (2003-10-21),

11. 5423367 - Blind with two-part angular slats having cord passing slots formed only (1995-06-13),

Title: Kenichi Saitoh: Innovator in Pharmaceutical Chemistry

Introduction

Kenichi Saitoh is a prominent inventor based in Tokyo, Japan, known for his significant contributions to pharmaceutical chemistry. With a total of 11 patents to his name, Saitoh has made remarkable advancements in the field of medicinal compounds.

Latest Patents

Among his latest patents, Saitoh has developed a novel purine derivative and an antitumor agent utilizing this compound. This patent discloses a unique purine derivative, a composition thereof, and a method for treating tumors using the purine derivative. Specifically, it includes a compound represented by a specific formula, along with its pharmaceutically acceptable salts, solvates, or hydrates. Additionally, he has disclosed methods for treating depression, neurodegeneration, inhibiting amyloid β deposition, delaying senescence, and extending life spans with heterocyclic compounds. This patent presents an antidepressant, neuroprotectant, and age retardant composition containing a heterocyclic compound with a general formula.

Career Highlights

Throughout his career, Kenichi Saitoh has worked with notable companies, including Zenyaku Kogyo Kabushiki Kaisha and Nichibei Corporation. His work has significantly impacted the development of new therapeutic agents.

Collaborations

Saitoh has collaborated with esteemed colleagues such as Toshiyuki Matsuno and Seiichiro Kawashima, contributing to various innovative projects in the pharmaceutical sector.

Conclusion

Kenichi Saitoh's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to influence the development of new treatments and therapeutic agents.

This text is generated by artificial intelligence and may not be accurate.